📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

Refining Therapy in Patients with HER2-Positive Breast Cancer with Central Nervous System Metastasis. (2022)

First Author: Batista MFFV

Attributed to: Identifying molecular drivers and early diagnostic biomarkers in breast cancer leptomeningeal metastasis by the interrogation of cerebrospinal fluid funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1159/000526431

PubMed Identifier: 36590149

Publication URI: http://europepmc.org/abstract/MED/36590149

Type: Journal Article/Review

Volume: 17

Parent Publication: Breast care (Basel, Switzerland)

Issue: 6

ISSN: 1661-3791